Actinium Pharmaceuticals reported $1000 in Interest Expense on Debt for its fiscal quarter ending in December of 2024.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Actinium Pharmaceuticals USD 1000 1000 Dec/2024
Amgen USD 653M 32M Dec/2025
Bioline Rx USD 360K 84K Sep/2025
Capricor Therapeutics 581K 581K Dec/2024
Pfizer USD 711M 59M Dec/2025